Related Experiment Video
Updated: May 22, 2025
Robotic Left Hepatectomy using Indocyanine Green Fluorescence Imaging for an Intrahepatic Complex Biliary Cyst
Published on: June 24, 2022
[The Short-Term Outcome of Robotic Liver Resection-A Single Institutional Experience]
Yutaka Takeda1, Yoshiaki Ohmura, Go Shinke
1Dept. of Surgery, Kansai Rosai Hospital.
Introduction:
Robotic liver resection(RLR)has been covered by insurance since 2022. We report our short-term outcomes of RLR performed in Kansai Rosai Hospital.
Patients And Method:
Between May 2022 and November 2023, 35 patients underwent RLR. Control 789 patients who received laparoscopic liver resection(LLR)between January 2010 and November 2023 were included for comparison.
Results:
No significant differences were noted between non-anatomical RLR and anatomical RLR groups with respect to blood loss, Pringle rate, conversion rate, biliary fistula and hospital stay, respectively. Difficulty score was higher(4.07 vs 7.71 p<0.0001)and console time was longer(212 vs 331 min p=0.0035)in anatomical RLR group than non-anatomical RLR group. No significant differences were noted between RLR and LLR groups with respect to patient age, gender, Child-Pugh, liver damage and diagnosis, respectively. Anatomical LR rate was higher(18/17 vs 534/255, 48.6 vs 32.3%, p=0.0454)and open conversion rate was lower(0 vs 0.5%, p=0.0296)in RLR group than LLR group. No significant differences were noted between RLR and LLR groups with respect to blood loss, postoperative mortality, morbidity and hospital stay, respectively.
Conclusion:
Although further studies are still needed to confirm the benefit of RLR, RLR is safe, minimally invasive, and effective approach to the management of liver tumor.
